EMCDDA Home
  • EN
Search

Please note that the information on this page is based on the EMCDDA Annual report 2011: the state of the drugs problem in Europe. Most statistical data relate to the year 2009 (or the last year available).

Annual report 2011: the state of the drugs problem in Europe
Cannabis

Published: 15 November 2011

Introduction

Cannabis is the illicit drug most widely available in Europe, where it is both imported and produced domestically. In most European countries, cannabis use increased during the 1990s and early 2000s. Europe may now be moving into a new phase, as data from general population and school surveys point to a stabilising or even decreasing trend in cannabis use in many countries. Levels of use, nevertheless, remain high by historical standards. The last few years have also seen a growing understanding of the public health implications of the long-term and widespread use of this drug, and rising levels of treatment demand for cannabis-related problems. Therefore, what constitutes an effective response to cannabis use remains a key question in the European debate on drugs.

About the EMCDDA

The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) is the reference point on drugs and drug addiction information in Europe. Inaugurated in Lisbon in 1995, it is one of the EU's decentralised agencies. Read more >>

Contact us

EMCDDA
Praça Europa 1, Cais do Sodré
1249-289 Lisbon
Portugal
Tel. (351) 211 21 02 00

More contact options >>

Page last updated: Friday, 28 October 2011